Bioptik Technology Incorporation (TPEX:4161)

Market Cap	1.45B -20.8%
Revenue (ttm)	837.19M -3.3%
Net Income	71.19M -23.9%
EPS	1.21 -23.9%
Shares Out	59.81M
PE Ratio	20.00
Forward PE	n/a
Dividend	0.70 (2.89%)
Ex-Dividend Date	n/a

Volume	7,064
Average Volume	109,940
Open	24.35
Previous Close	24.20
Day's Range	24.00 - 24.35
52-Week Range	23.70 - 30.50
Beta	0.37
RSI	39.92
Earnings Date	May 8, 2026

About TPEX:4161

Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. The company offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch, a glucose monitoring system for dogs and cats. It also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy; cosmetic products, including sunscree...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4161

Financial Performance

In 2025, TPEX:4161's revenue was 837.19 million, a decrease of -3.25% compared to the previous year's 865.34 million. Earnings were 71.19 million, a decrease of -23.92%.